Indeed, recent studies showed that re-sensitisation of leptin signalling mediated by neutralising antibodies restores both leptin and insulin sensitivity, promoting weight lowering and thermogenic activation and thus constituting a promising therapy against leptin resistance in obesity. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.